%0 Journal Article
%A Paul Magill
%A Janet C. Hill
%A Leeann Bryce
%A Una Martin
%A Al Dorman
%A Rosemary Hogg
%A Christina Campbell
%A Evie Gardner
%A Margaret McFarland
%A Jennifer Bell
%A Gary Benson
%A David Beverland
%T Oral tranexamic acid for an additional 24 hours postoperatively versus a single preoperative intravenous dose for reducing blood loss in total knee arthroplasty: results of a randomized controlled trial (TRAC-24)
%D 2021
%J The Bone & Joint Journal
%P 1595-1603
%V 103-B
%N 10
%R 10.1302/0301-620X.103B10.BJJ-2020-2308.R1
%U https://doi.org/10.1302/0301-620X.103B10.BJJ-2020-2308.R1
%K Tranexamic,Blood,Knee,Arthroplasty,High-risk,tranexamic acid,blood loss,randomized controlled trial,total knee arthroplasty (TKA),venous thromboembolism (VTE),BMI,Oxford Knee Score,Paired t-test,standard deviation,chi-squared test